Kevin M. Picardat

Array ( [id] => 715829 [patent_doc_number] => 07053055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-30 [patent_title] => 'Compounds of unstable DP IV-inhibitors' [patent_app_type] => utility [patent_app_number] => 09/745883 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5509 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/053/07053055.pdf [firstpage_image] =>[orig_patent_app_number] => 09745883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1133475 [patent_doc_number] => 06783960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-31 [patent_title] => 'Chimeric proteins' [patent_app_type] => B2 [patent_app_number] => 09/741106 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 12988 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783960.pdf [firstpage_image] =>[orig_patent_app_number] => 09741106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818230 [patent_doc_number] => 20030069188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders' [patent_app_type] => new [patent_app_number] => 09/738948 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5190 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09738948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818230 [patent_doc_number] => 20030069188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders' [patent_app_type] => new [patent_app_number] => 09/738948 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5190 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09738948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6875690 [patent_doc_number] => 20010000784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-03 [patent_title] => 'METHOD OF SUPRESSING IMMUNE RESPONSES BY REDUCING INTRACELLULAR CONTENT OF GLUTATHIONE IN MACROPHAGES AND MONOCYTES' [patent_app_type] => new-utility [patent_app_number] => 09/731830 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21998 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0000/20010000784.pdf [firstpage_image] =>[orig_patent_app_number] => 09731830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1361647 [patent_doc_number] => 06573361 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Antifungal proteins and methods for their use' [patent_app_type] => B1 [patent_app_number] => 09/732210 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19131 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573361.pdf [firstpage_image] =>[orig_patent_app_number] => 09732210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6015753 [patent_doc_number] => 20020102604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Full-length human cDNAs encoding potentially secreted proteins' [patent_app_type] => new [patent_app_number] => 09/731872 [patent_app_country] => US [patent_app_date] => 2000-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 269369 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20020102604.pdf [firstpage_image] =>[orig_patent_app_number] => 09731872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6619199 [patent_doc_number] => 20020086036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Methods for treating hyperhidrosis' [patent_app_type] => new [patent_app_number] => 09/730237 [patent_app_country] => US [patent_app_date] => 2000-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10913 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086036.pdf [firstpage_image] =>[orig_patent_app_number] => 09730237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326637 [patent_doc_number] => 07514408 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-04-07 [patent_title] => 'β-secretase enzyme compositions and methods' [patent_app_type] => utility [patent_app_number] => 09/730329 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 58 [patent_no_of_words] => 30673 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514408.pdf [firstpage_image] =>[orig_patent_app_number] => 09730329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921546 [patent_doc_number] => 20010029031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Polynucleotides encoding human sodium bicarbonate cotransporters' [patent_app_type] => new [patent_app_number] => 09/728137 [patent_app_country] => US [patent_app_date] => 2000-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10602 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029031.pdf [firstpage_image] =>[orig_patent_app_number] => 09728137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387985 [patent_doc_number] => 06548481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Effectors of dipeptidyl peptidase IV' [patent_app_type] => B1 [patent_app_number] => 09/723638 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5326 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548481.pdf [firstpage_image] =>[orig_patent_app_number] => 09723638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1147186 [patent_doc_number] => 06774103 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Compounds for deactivating phospholamban function on Ca-ATPase (phospholamban inhibitors)' [patent_app_type] => B1 [patent_app_number] => 09/722440 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 37450 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774103.pdf [firstpage_image] =>[orig_patent_app_number] => 09722440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1228475 [patent_doc_number] => 06696412 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-24 [patent_title] => 'High purity lipopeptides, Lipopeptide micelles and processes for preparing same' [patent_app_type] => B1 [patent_app_number] => 09/735191 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 20419 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696412.pdf [firstpage_image] =>[orig_patent_app_number] => 09735191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560740 [patent_doc_number] => 06437093 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Methods of treatment comprising administration of Substance P' [patent_app_type] => B1 [patent_app_number] => 09/723699 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1315 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/437/06437093.pdf [firstpage_image] =>[orig_patent_app_number] => 09723699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1156791 [patent_doc_number] => 06762167 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-07-13 [patent_title] => 'Methods for treating a patient undergoing chemotherapy' [patent_app_type] => B1 [patent_app_number] => 09/723197 [patent_app_country] => US [patent_app_date] => 2000-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 12873 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/762/06762167.pdf [firstpage_image] =>[orig_patent_app_number] => 09723197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1399983 [patent_doc_number] => 06534283 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Method for treatment and prevention of physiological shock' [patent_app_type] => B1 [patent_app_number] => 09/718783 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4540 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534283.pdf [firstpage_image] =>[orig_patent_app_number] => 09718783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413183 [patent_doc_number] => 06514481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Magnetic nanoparticles for selective therapy' [patent_app_type] => B1 [patent_app_number] => 09/718825 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 3664 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514481.pdf [firstpage_image] =>[orig_patent_app_number] => 09718825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241229 [patent_doc_number] => 06683052 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Lipopeptides containing an interferon- fragment, and uses thereof in pharmaceutical compositions' [patent_app_type] => B1 [patent_app_number] => 09/601729 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 27433 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683052.pdf [firstpage_image] =>[orig_patent_app_number] => 09601729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1327687 [patent_doc_number] => 06599875 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-29 [patent_title] => 'IL-6 antagonist peptides' [patent_app_type] => B1 [patent_app_number] => 09/715923 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 6310 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599875.pdf [firstpage_image] =>[orig_patent_app_number] => 09715923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1300225 [patent_doc_number] => 06624144 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Matrix metalloproteinase inhibitors and down-regulators' [patent_app_type] => B1 [patent_app_number] => 09/646423 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 8070 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624144.pdf [firstpage_image] =>[orig_patent_app_number] => 09646423 [rel_patent_id] =>[rel_patent_doc_number] =>)